Warning: Undefined array key "network" in /hshare1/ZETTAI_path_WA_slash_usr_slash_proj_KARA/usr/proj/tcng/htdocs/tcng.php on line 565

Edge

KPNA1 → TAGLN2

GSE13911_egf1520 - GSE13911 - SiGN-BN HC+Bootstrap	Expression data from primary gastric tumors (MSI and MSS) and adjacent normal samples
GSE15966_egf1520 - GSE15966 - SiGN-BN HC+Bootstrap	Gene expression signature predictive of rapid response to imatinib mesylate in Gastrointestinal Stromal Tumor (GIST)
GSE18520_egf1520 - GSE18520 - SiGN-BN HC+Bootstrap	Whole-genome oligonucleotide expression analysis of papillary serous ovarian adenocarcinomas
GSE19784_egf1520 - GSE19784 - SiGN-BN HC+Bootstrap	Gene expression profiling of multiple myeloma patients included in the HOVON65/GMMG-HD4 trial
GSE20181_egf1520 - GSE20181 - SiGN-BN HC+Bootstrap	Letrozole (Femara) early and late responses to treatment
GSE20916_egf1520 - GSE20916 - SiGN-BN HC+Bootstrap	Modeling oncogenic signaling in colon tumors by multidirectional analyses of microarray data
GSE21653_egf1520 - GSE21653 - SiGN-BN HC+Bootstrap	A gene expression signature identifies two prognostic subgroups of basal breast cancer
GSE2990_egf1520 - GSE2990 - SiGN-BN HC+Bootstrap	Gene Expression Profiling in Breast Cancer: Understanding the Molecular Basis of Histologic Grade To Improve Prognosis
GSE30784_egf1520 - GSE30784 - SiGN-BN HC+Bootstrap	Gene expression profiling of oral squamous cell carcinoma (OSCC)
GSE5462_egf1520 - GSE5462 - SiGN-BN HC+Bootstrap	Letrozole (Femara) early response to treatment
GSE6791_egf1520 - GSE6791 - SiGN-BN HC+Bootstrap	Gene Expression Profiles of HPV-Positive and -Negative Head/Neck and Cervical Cancers